升压素
中文名称 | 升压素 |
---|---|
中文同义词 | 运动升压素;升压素 |
英文名称 | KINETENSIN |
英文同义词 | KINETENSIN;KINETENSIN (HUMAN);IARRHPYFL;ILE-ALA-ARG-ARG-HIS-PRO-TYR-PHE-LEU;H-ILE-ALA-ARG-ARG-HIS-PRO-TYR-PHE-LEU-OH;NEUROTENSIN-RELATED PEPTIDE;NRP;253: PN: WO0069900 SEQID |
CAS号 | 103131-69-7 |
分子式 | C56H85N17O11 |
分子量 | 1172.38 |
EINECS号 | |
相关类别 | 细胞信号和神经生物学;多肽;细胞生物学;标准品;Peptide;Neuropeptides;Neurotensins;Peptides for Cell Biology;Neuromedins and related |
Mol文件 | 103131-69-7.mol |
结构式 |
升压素 性质
储存条件 | 2-8°C |
---|---|
溶解度 | TFA 0.1%:1 mg/mL,澄清,无色 |
形态 | 粉末 |
水溶解性 | Soluble to 2 mg/ml in water |
Neurotensin Receptor
The peptide kinetensin isolated from pepsin-treated human plasma induces a dose-dependent release of histamine when exposed to rat peritoneal mast cells. The threshold concentration is around 1 μM, the ED 50 is 10 μM, and the optimal concentration of between 100 to 1000 μM released 80% of the total histamine. Kinetensin is 10 to 100 times less potent than neurotensin and equipotent with the opioid peptide dynorphin. The histamine release is clearly temperature-dependent, with no release occurring at 0 or 45 °C and with an optimum around 37 °C. The histamine release is significantly reduced in the absence of extracellular calcium.
Kinetensin also induces a dose-dependent increase in vascular permeability when injected intradermally into rats.
提供商 | 语言 |
---|---|
英文
|
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/04/30 | HY-P1255 | 升压素 Kinetensin | 103131-69-7 | 1mg | 918元 |
2024/04/30 | HY-P1255 | 升压素 Kinetensin | 103131-69-7 | 5mg | 1830元 |